Before asking whether myo-inositol “works” for insulin resistance, it helps to ask who the studies were actually done on, because the answer changes depending on that.
Quick answer: Myo-inositol is a sugar-like compound your body makes and that is involved in how cells respond to insulin. Most of the controlled trials are in women with polycystic ovary syndrome (PCOS) or gestational diabetes, and in those groups several meta-analyses report modest average improvements in fasting insulin and HOMA-IR. The evidence in people with ordinary prediabetes or type 2 diabetes is much thinner, and nothing in the literature supports it as a replacement for prescribed treatment.
Why people with insulin resistance look at myo-inositol
Inositol shows up on supplement shelves next to berberine and chromium, usually marketed as a “natural insulin sensitizer.” The pitch has a plausible mechanism behind it. Inositol is a building block of molecules called inositol phosphoglycans, which act as second messengers inside cells after insulin binds to its receptor. The idea is that if those messengers are in short supply, insulin’s signal gets lost, and that restoring inositol helps the message get through.
That mechanism is real in the lab. Whether it translates into a meaningful change in a person’s fasting glucose or HOMA-IR is a separate question, and it is the one the trials try to answer.
If you are still getting oriented on what insulin resistance means and how it is measured, the insulin resistance guide covers the basics before you get into any specific supplement.
What the research actually shows
The strongest body of evidence is in PCOS. Multiple randomized controlled trials, mostly small (often 30 to 100 participants) and short (typically 12 to 24 weeks), compared myo-inositol to placebo or to metformin. Meta-analyses pooling these trials have generally reported that myo-inositol was associated with lower fasting insulin and lower HOMA-IR than placebo, with effects on fasting glucose that were smaller and less consistent. Several reviews describe the glucose and insulin results as similar to metformin in these specific populations, with fewer gastrointestinal complaints.
A second body of evidence is in pregnancy. Trials in women at higher risk for gestational diabetes reported fewer diagnoses of gestational diabetes in the myo-inositol groups than in the control groups. A Cochrane review judged the certainty of that evidence as low, mainly because of small trials and risk of bias, and called for larger studies.
In adults with prediabetes or type 2 diabetes who do not have PCOS, the evidence is sparse. There are a handful of small trials and some mechanistic studies, and a few reported improvements in fasting glucose or insulin sensitivity markers, but sample sizes were small and the trials were short. That is not enough to draw conclusions for the typical reader of this site.
What the research does not show matters just as much:
- It does not show that myo-inositol reduces heart attacks, strokes, or diabetes complications. No trial has been designed or powered to look at those outcomes.
- It does not show large A1C changes. Where A1C was measured, changes were small, and averages across a trial are not a prediction of what happens in any one person.
- It does not show lasting benefit after stopping. Trials rarely followed participants once supplementation ended.
You can scan the primary literature yourself with a PubMed search for myo-inositol and insulin resistance trials. Look at the population, the duration, and the comparison group before reading the abstract’s conclusion.
Why PCOS results may not transfer to you
Insulin resistance in PCOS has some features that are not identical to insulin resistance driven mainly by weight, inactivity, sleep debt, or age. Some researchers have proposed that PCOS involves a specific disturbance in how the ovary and other tissues handle inositol, which would explain why inositol supplementation seems to do more there than in general populations.
If that hypothesis holds, a man with prediabetes and a woman with PCOS are not the same experiment. It is reasonable to be interested in inositol either way, but it is also reasonable to expect smaller effects, or none, outside the groups where the data were collected. The overlap between PCOS and metabolic syndrome is covered in more detail in Inositol, PCOS, and Metabolic Syndrome.
Forms and doses as studied
Most trials used myo-inositol powder, often 2 grams twice daily (4 grams total), sometimes combined with a small amount of folic acid. Some used a myo-inositol to D-chiro-inositol combination in a 40:1 ratio, which is discussed in Myo-Inositol vs. D-Chiro-Inositol. The amounts and schedules that appear across the trials are collected in Inositol Dosage and Timing.
Those are the amounts researchers chose for their trials. They are not a recommendation. The right amount for you, if any, depends on your medications, kidney function, and what you are trying to change, and that is a clinician question.
How to read an inositol label
Three things to check:
- Which inositol. “Inositol” on the front of a bottle almost always means myo-inositol, but the supplement facts panel should say so. If it lists D-chiro-inositol, note the ratio.
- Serving size versus the trial amounts. Capsules often contain 500 mg to 1,000 mg each. If a trial used 4 grams a day, that is four to eight capsules, which is why most trials used powder.
- What else is in it. Blends that add chromium, berberine, cinnamon, or alpha-lipoic acid make it impossible to know what caused any change you notice, and they stack up interaction concerns. For context, Metabolic Clarity Labs sells a berberine product; hold MCL to the same standard you would hold anyone else, and do not combine products without talking to your prescriber.
Third-party testing seals (USP, NSF, Informed Choice) tell you the bottle contains what the label says. They do not tell you it works.
Safety and interactions
Myo-inositol at the amounts used in trials was generally well tolerated. The most common side effects were mild digestive ones: nausea, gas, and loose stools, more often at higher amounts. There is a specific caution for people with bipolar disorder or those taking lithium: inositol is involved in the pathway lithium acts on, and there are case reports of mood changes with high-dose inositol. That is a conversation for a psychiatrist, not a supplement aisle.
Hypoglycemia warning: Combining any blood-sugar-active supplement with insulin, sulfonylureas, or other glucose-lowering medicines can push glucose too low. Symptoms include shakiness, sweating, confusion, and a fast heartbeat. Do not add a supplement to a medication plan without your prescriber’s knowledge.
A fuller list, including pregnancy, kidney concerns, and what to track if you and your clinician decide to try it, is in Inositol Side Effects and Medication Questions. For a general overview of how supplements are regulated and what claims mean, the NCCIH page on using dietary supplements wisely is a good baseline.
Questions to bring to your appointment
- Do my labs point to insulin resistance specifically, or to something else? What is my fasting insulin, and have we calculated HOMA-IR?
- Given that most inositol trials were in PCOS or pregnancy, do you think the results apply to my situation?
- Here is my full medication list, including over-the-counter products. Does inositol interact with any of them, especially anything that lowers glucose or anything for mood?
- If I try it, what should we measure, and at what interval, to decide whether it is doing anything? Fasting glucose, fasting insulin, A1C?
- What would make you say stop?
- Where does this fit relative to the things with stronger evidence, like sleep, activity, and dietary pattern?
Inositol is one of the more interesting supplements on the metabolic syndrome supplements list, with a real mechanism and real trials. The trials just were not run on most of the people buying it. Keep that in mind, and let your own measurements, not the label, decide whether it earns a place.
About the author: Charles Kirkland is the founder of Metabolic Clarity Labs and author of The Journey Back. He is not a physician. This is general education, not a medically reviewed treatment plan.
Sources checked October 29, 2026. Discuss personal decisions with a qualified clinician or pharmacist. Do not start, stop, or change prescribed treatment based on this article.
Related reading: Supplements for Insulin Resistance.
Leave a Reply